We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

75 hedge funds and large institutions have $137M invested in BioDelivery Sciences International, Inc. in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $521K

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

35% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 20

10% more funds holding

Funds holding: 6875 (+7)

2% more capital invested

Capital invested by funds: $133M → $137M (+$3.12M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
27
Reduced
20
Closed
10
Calls
$1.07M
Puts
$521K
Net Calls
+$549K
Net Calls Change
+$530K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.2M -$14.2M -2,761,669 -49%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$13.5M
BC
3
Broadfin Capital
New York
$13.1M +$515K +100,000 +5%
DM
4
Deerfield Management
New York
$10.4M -$4.42M -856,861 -33%
VAM
5
Visium Asset Management
New York
$10M +$3.09M +600,000 +55%
BIT
6
BlackRock Institutional Trust
California
$7.13M -$124K -23,976 -2%
TAM
7
THB Asset Management
Connecticut
$6.05M +$1.14M +221,261 +27%
BBA
8
Baker Bros. Advisors
New York
$4.98M
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.84M +$141K +27,343 +3%
BFA
10
BlackRock Fund Advisors
California
$4.77M -$190K -36,815 -4%
SC
11
Sophrosyne Capital
New York
$4.09M -$4.02M -779,944 -53%
Federated Hermes
12
Federated Hermes
Pennsylvania
$3.43M +$85.5K +16,591 +3%
TCM
13
Tekla Capital Management
Massachusetts
$3.43M +$3M +581,860 New
TM
14
Tiger Management
New York
$3.01M +$2.63M +510,874 New
GIM
15
Granahan Investment Management
Massachusetts
$2.99M +$2.61M +507,251 New
KCM
16
Kennedy Capital Management
Missouri
$2.62M +$744K +144,363 +48%
Northern Trust
17
Northern Trust
Illinois
$2.54M +$24.3K +4,722 +1%
Allianz Asset Management
18
Allianz Asset Management
Germany
$2.25M +$767K +148,835 +64%
State Street
19
State Street
Massachusetts
$2.18M -$4.69K -910 -0.2%
Millennium Management
20
Millennium Management
New York
$2.13M +$1.71M +331,566 +1,106%
B
21
Bailard
California
$1.43M +$1.01M +195,414 +408%
SKK
22
Shepherd Kaplan Krochuk
Massachusetts
$1.42M +$130K +25,256 +12%
TCM
23
Timpani Capital Management
Wisconsin
$1.4M +$1.23M +238,454 New
TAM
24
Tocqueville Asset Management
New York
$891K +$22.2K +4,300 +3%
JP Morgan Chase
25
JP Morgan Chase
New York
$862K -$18.6K -3,618 -2%

BDSI Hedge Fund Activity: Q4 2013 in Review

75 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2013, worth a combined $137M — up 2.3% from $133M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BDSI positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 20 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $3.09M. The largest seller was Fidelity Investments, cutting an estimated $14.2M.

  • 75 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2013, up from 68 in Q3 2013.
  • Funds reported $137M of BioDelivery Sciences International, Inc. stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 17 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2013 and 10 closed out, a net change of +7 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $3.09M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2013 was Fidelity Investments, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2013.